ncq 298 has been researched along with raclopride in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
| Farde, L; Hall, H; Halldin, C; Högberg, T; Larsson, S; Sedvall, G | 1 |
| Farde, L; Hall, H; Halldin, C; Högberg, T; Köhler, C; Larsson, SA; Ross, SB; Ström, P | 1 |
| Farde, L; Hall, H; Halldin, C; Högberg, T; Köhler, C; Ström, P | 1 |
| Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
| Jarrott, B; Lawrence, AJ | 1 |
| Fazio, F; Guibert, B; Leviel, V; Loc'h, C; Maziere, B; Maziere, M; Moresco, RM; Ottaviani, M | 1 |
1 review(s) available for ncq 298 and raclopride
| Article | Year |
|---|---|
Imaging of dopamine receptors using PET and SPECT.
Topics: Animals; Benzamides; Brain; Dopamine Agonists; Dopamine Antagonists; Humans; Macaca fascicularis; Pyrrolidines; Raclopride; Receptors, Dopamine; Salicylamides; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |
6 other study(ies) available for ncq 298 and raclopride
| Article | Year |
|---|---|
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
Topics: Animals; Autoradiography; Binding, Competitive; Brain; Dopamine Agents; Dopamine Antagonists; Iodine Radioisotopes; Macaca fascicularis; Male; Mice; Raclopride; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Sodium; Species Specificity; Tomography, Emission-Computed, Single-Photon | 1991 |
Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.
Topics: Animals; Dopamine Agents; In Vitro Techniques; Iodine Radioisotopes; Raclopride; Rats; Receptors, Dopamine; Salicylamides | 1990 |
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Visualization of dopamine D2 binding sites on human inferior vagal ganglia.
Topics: Autoradiography; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Ligands; Male; Neurons, Afferent; Nodose Ganglion; Pressoreceptors; Raclopride; Receptors, Dopamine D2; Salicylamides | 1994 |
Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Cerebellum; Dopamine; Iodine Radioisotopes; Lisuride; Male; Nomifensine; Raclopride; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed; Tritium; Visual Cortex | 1999 |